Home  |  About this Journal  |  Authors  |  Referees  |  Editors  |  Contact us  |  中文版
Cite this article as: Wang Yu-Ting,Liu Meng-Ting,Wang Yan-Wen,Hou Qing-Mei,Yang Li-Quan,Sang Peng. Molecular mechanism of EGFR rare mutation (S768I)-induced NSCLC based on structural dynamics [J]. J. At. Mol. Phys.(原子与分子物理学报), 2025, 42: 011007 (in Chinese)
Molecular mechanism of EGFR rare mutation (S768I)-induced NSCLC based on structural dynamics
Hits 71  Download times 23  Received:April 27, 2023  Revised:June 14, 2023
View Full Text  View/Add Comment  Download reader
DOI   10.19855/j.1000-0364.2025.011007
Key Words   EGFR  S768I  molecular dynamics simulation  essential dynamics  free energy landscape
Author NameAffiliationE-mail
Wang Yu-Ting* 大理大学 yutingw_v@163.com 
Liu Meng-Ting 大理大学  
Wang Yan-Wen 大理大学  
Hou Qing-Mei 大理大学  
Yang Li-Quan 大理大学  
Sang Peng 大理大学  
Abstract
    Epidermal growth factor receptor (EGFR) gene mutation is an important cause of non-small cell lung cancer (NSCLC). The S768I point mutation is a rare mutation of EGFR, and there is no standard targeted therapy at present. Therefore, a detailed understanding of the structural differences between the EGFR S768I mutant and the wild type(WT)is crucial for the development of related drugs. In order to probe the role of the S768I mutation in NSCLC, we performed molecular dynamics (MD) simulations, essential dynamics (ED) analyses, and free energy landscape (FEL) constructions on WT and S768I mutant EGFR. MD simulations suggest that the S768I mutation increases both of the global and local flexibility of EGFR. The large concerted motions derived from ED analyses indicate that two important structural elements A-loop and αC-helix which distinguish the active state from the inactive state both have a more pronounced tendency to transition to the active state in S768I mutant than in WT. The free energy calculations reveal a more rugged and complex FEL for the S768I mutant than for the WT EGFR, implying that the mutant form has a richer conformational diversity. The study provides a reasonable molecular mechanism explanation for S768I mutations leading to NSCLC, and provide assistance for the development of new targeted therapeutic drugs for patients with S768I mutations.

You are the 125756 visitor.

Copyright @ 2007Editorial Office of Journal of Atomic and Molecular Physics
Address: Institute of Atomic and Molecular Physics, Sichuan University  Postcode: Chengdu 610065
Tel:QQ: 3094757965  Fax:  E-mail: jamp@scu.edu.cn
Beijing E-Tiller Co., Ltd.